WHAT: The Cancer Center Council, in support of the Cancer Therapy & Research Center (CTRC) at The UT Health Science Center, presents the Fifteenth Annual Spring Luncheon featuring Dr. Dan Shapiro.
Dr. Shapiro is an associate professor in the College of Medicine at the University of Arizona where he directs the Medical Humanities Program and Behavioral Science education for the medical students. His research focuses on coping with medical crises and physician-patient communication. An entertaining and inspirational speaker, Dr. Shapiro uses his expertise and own experiences as someone who has lived on “both sides of the medical bed,” to relate to individuals facing their own medical crises.
The mission of the Cancer Center Council is to support the Cancer Therapy & Research Center at The UT Health Science Center at San Antonio. Proceeds from the event benefit the CTRC Patient Assistance Fund, which provides food, lodging and transportation to patients in need.
Individual tickets are $50. For additional information, call the CCC office at (210) 450-5571 or visit www.cancercentercouncil.net.
WHEN: Wednesday, March 12, 2008
Luncheon – 11:30 a.m.
WHERE: Pearl Stable
312 Pearl Parkway
San Antonio, Texas 78215
The Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio. Located in San Antonio, Texas, The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the nation’s leading academic research and treatment centers, serving more than 4.4 million people in the high-growth corridor of Central and South Texas including Austin, San Antonio, Laredo and the Rio Grande Valley. CTRC is one of a few elite cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only three in Texas. CTRC handles more than 120,000 patient visits each year and is a world leader in developing new drugs to treat cancer. The CTRC Institute for Drug Development (IDD) is internationally recognized for conducting the largest oncology Phase I clinical drug trials program in the world, and participated in the clinical and/or preclinical development of many of the cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit our Web site at www.ctrc.uthscsa.edu.